PhRMA says COVID-19 vaccine patent waiver is a ‘political stunt,’ while advocate argues it doesn’t go far enough FiercePharma
Covid-19 Variant Shot From Sanofi, GSK Effective Against Omicron – The Wall Street Journal
LONDON—GSK PLC and Sanofi SA reported promising trial results for their Covid-19 vaccine that showed the shot—developed to target the Beta strain of the virus—was particularly effective against the Omicron variant.The two companies said Friday that in a trial involving 13,000 adults, the vaccine demonstrated efficacy of 64.7% against symptomatic...